Overview

Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil)

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

This was a single centre, randomised, double blind, placebo controlled, two-way cross-over design study to assess the feasibility of pain PD tests and to determine the variability and effects of a known analgesic drug (the opioid remifentanil) in South Korean healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Analgesics
Analgesics, Opioid
Remifentanil